Does race belong in the hypertension guidelines?-Reference-Cited by-同舟云学术

Does race belong in the hypertension guidelines?

Published:2020-09-10 Issue:10 Volume:35 Page:940-941
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Gopal Dipesh P.^ORCID,Francis Rohin

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

https://www.nature.com/articles/s41371-020-00414-2.pdf

Reference15 articles.

1. NICE. Hypertension in adults: diagnosis and management. Manchester: National Institute for Health and Clinical Excellence; 2019. https://www.nice.org.uk/guidance/ng136.

2. Krimsky S. The short life of a race drug. Lancet. 2012;379:114–5.

3. Séguin B, Hardy B, Singer PA, Daar AS. Bidil: recontextualizing the race debate. Pharmacogenomics J. 2008;8:169–73.

4. Sagnella GA. Why is plasma renin activity lower in populations of African origin? J Hum Hypertens. 2000;15:17–25.

5. Spence JD, Rayner BL. Hypertension in Blacks: individualized therapy based on renin/aldosterone phenotyping. Hypertension. 2018;72:263–9.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicians’ perspectives on race-specific guidelines for hypertensive treatment;Social Science & Medicine;2024-06

2. Screening for hypertension in adults: protocol for evidence reviews to inform a Canadian Task Force on Preventive Health Care guideline update;Systematic Reviews;2024-01-05

3. Inequities in hypertension management: observational cross-sectional study in North East London using electronic health records;British Journal of General Practice;2023-08-02

4. Screening for hypertension in adults: protocol for evidence reviews to inform a Canadian Task Force on Preventive Health Care guideline update;2023-06-26

5. Race, ethnicity, and ill health: making the non-modifiable modifiable;The Lancet;2022-12